+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity

  • ID: 5319189
  • Report
  • April 2021
  • Region: Global
  • 165 pages
  • GMD Research

FEATURED COMPANIES

  • Aurobindo Pharma Ltd.
  • Cambrex Corporation
  • Catalent, Inc.
  • GlaxoSmithKline plc
  • Lonza Group
  • Merck & Co., Inc.
  • MORE
Global small molecule active pharmaceutical ingredient (API) market will reach $266.2 billion by 2027, growing by 7.3% annually over 2020-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic.



Highlighted with 85 tables and 85 figures, this 165-page report “Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global small molecule API market in every aspect of the classification from perspectives of Source, Type, Therapeutic Area, Application, Manufacturer Type, and Region.

Based on Source, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section.
  • Synthetic API
  • Branded Synthetic API
  • Generic Synthetic API
  • Semi-synthetic API
  • Natural Origin
Based on Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section.
  • Standard API
  • High Potency API (HPAPI)
  • Branded HPAPI
  • Generic HPAPI
Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section.
  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Cardiovascular Disorders
  • Central Nervous System
  • Respiratory Disorders
  • Metabolic Diseases
  • Other Applications
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section.
  • Clinical Use
  • Commercial Use
Based on Manufacturer Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2017-2027 included in each section.
  • Pharmaceutical Companies (also breakdown by region)
  • CMOs (also breakdown by region)
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • Aurobindo Pharma Ltd.
  • Cambrex Corporation
  • Catalent, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Lonza Group
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wuxi AppTec Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aurobindo Pharma Ltd.
  • Cambrex Corporation
  • Catalent, Inc.
  • GlaxoSmithKline plc
  • Lonza Group
  • Merck & Co., Inc.
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Global Market by Source
3.1 Market Overview by Source
3.2 Synthetic API
3.2.1 Branded Synthetic API
3.2.2 Generic Synthetic API
3.3 Semi-synthetic API
3.4 Natural Origin

4 Segmentation of Global Market by Type
4.1 Market Overview by Type
4.2 Standard API
4.3 High Potency API (HPAPI)
4.3.1 Branded HPAPI
4.3.2 Generic HPAPI

5 Segmentation of Global Market by Therapeutic Area
5.1 Market Overview by Therapeutic Area
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Respiratory Disorders
5.8 Metabolic Diseases
5.9 Other Applications

6 Segmentation of Global Market by Application
6.1 Market Overview by Application
6.2 Clinical Use
6.3 Commercial Use

7 Segmentation of Global Market by Manufacturer Type
7.1 Market Overview by Manufacturer Type
7.2 Pharmaceutical Companies
7.3 CMOs

8 Segmentation of Global Market by Region
8.1 Geographic Market Overview 2020-2027
8.2 North America Market 2020-2027 by Country
8.2.1 Overview of North America Market
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 European Market 2020-2027 by Country
8.3.1 Overview of European Market
8.3.2 UK
8.3.3 France
8.3.4 Germany
8.3.5 Spain
8.3.6 Italy
8.3.7 Russia
8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2020-2027 by Country
8.4.1 Overview of Asia-Pacific Market
8.4.2 China
8.4.3 Japan
8.4.4 India
8.4.5 Australia
8.4.6 South Korea
8.4.7 Rest of APAC Region
8.5 South America Market 2020-2027 by Country
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America Market
8.6 MEA Market 2020-2027 by Country
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Other National Markets

9 Competitive Landscape
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
  • Aurobindo Pharma Ltd.
  • Cambrex Corporation
  • Catalent, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Lonza Group
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wuxi AppTec Co., Ltd.
10 Investing in Global Market: Risk Assessment and Management
10.1 Risk Evaluation of Global Market
10.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Global Small Molecule API Market in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Main Product Trends and Market Opportunities in Global Small Molecule API Market
Table 4. Global Small Molecule API Market by Source, 2017-2027, $ mn
Table 5. Global Small Molecule API Market: Synthetic API by Drug Type, 2017-2027, $ mn
Table 6. Global Small Molecule API Market by Type, 2017-2027, $ mn
Table 7. Global Small Molecule API Market: HPAPI by Drug Type, 2017-2027, $ mn
Table 8. Global Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 9. Global Small Molecule API Market by Application, 2017-2027, $ mn
Table 10. Global Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 11. Global Small Molecule API Market by Region, 2017-2027, $ mn
Table 12. Leading National Small Molecule API Market, 2020 and 2027, $ mn
Table 13. North America Small Molecule API Market by Country, 2017-2027, $ mn
Table 14. U.S. Small Molecule API Market by Type, 2017-2027, $ mn
Table 15. U.S. Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 16. U.S. Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 17. Canada Small Molecule API Market by Type, 2017-2027, $ mn
Table 18. Canada Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 19. Canada Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 20. Mexico Small Molecule API Market by Type, 2017-2027, $ mn
Table 21. Mexico Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 22. Mexico Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 23. Europe Small Molecule API Market by Country, 2017-2027, $ mn
Table 24. UK Small Molecule API Market by Type, 2017-2027, $ mn
Table 25. UK Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 26. UK Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 27. France Small Molecule API Market by Type, 2017-2027, $ mn
Table 28. France Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 29. France Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 30. Germany Small Molecule API Market by Type, 2017-2027, $ mn
Table 31. Germany Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 32. Germany Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 33. Spain Small Molecule API Market by Type, 2017-2027, $ mn
Table 34. Spain Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 35. Spain Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 36. Italy Small Molecule API Market by Type, 2017-2027, $ mn
Table 37. Italy Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 38. Italy Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 39. Russia Small Molecule API Market by Type, 2017-2027, $ mn
Table 40. Russia Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 41. Russia Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 42. Small Molecule API Market in Rest of Europe by Country, 2017-2027, $ mn
Table 43. APAC Small Molecule API Market by Country, 2017-2027, $ mn
Table 44. China Small Molecule API Market by Type, 2017-2027, $ mn
Table 45. China Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 46. China Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 47. Japan Small Molecule API Market by Type, 2017-2027, $ mn
Table 48. Japan Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 49. Japan Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 50. India Small Molecule API Market by Type, 2017-2027, $ mn
Table 51. India Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 52. India Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 53. Australia Small Molecule API Market by Type, 2017-2027, $ mn
Table 54. Australia Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 55. Australia Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 56. South Korea Small Molecule API Market by Type, 2017-2027, $ mn
Table 57. South Korea Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 58. South Korea Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 59. Small Molecule API Market in Rest of APAC by Country/Region, 2017-2027, $ mn
Table 60. South America Small Molecule API Market by Country, 2017-2027, $ mn
Table 61. Argentina Small Molecule API Market by Type, 2017-2027, $ mn
Table 62. Argentina Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 63. Argentina Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 64. Brazil Small Molecule API Market by Type, 2017-2027, $ mn
Table 65. Brazil Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 66. Brazil Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 67. Chile Small Molecule API Market by Type, 2017-2027, $ mn
Table 68. Chile Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 69. Chile Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 70. MEA Small Molecule API Market by Country, 2017-2027, $ mn
Table 71. UAE Small Molecule API Market by Type, 2017-2027, $ mn
Table 72. UAE Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 73. UAE Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 74. Saudi Arabia Small Molecule API Market by Type, 2017-2027, $ mn
Table 75. Saudi Arabia Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 76. Saudi Arabia Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 77. South Africa Small Molecule API Market by Type, 2017-2027, $ mn
Table 78. South Africa Small Molecule API Market by Therapeutic Area, 2017-2027, $ mn
Table 79. South Africa Small Molecule API Market by Manufacturer Type, 2017-2027, $ mn
Table 80. Aurobindo Pharma Ltd.: Company Snapshot
Table 81. Aurobindo Pharma Ltd.: Business Segmentation
Table 82. Aurobindo Pharma Ltd.: Product Portfolio
Table 83. Aurobindo Pharma Ltd.: Revenue, 2017-2019, $ mn
Table 84. Risk Evaluation for Investing in Global Market, 2020-2027
Table 85. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 5. Global Small Molecule API Market, 2017-2027, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Small Molecule API Market
Figure 8. Primary Restraints and Impact Factors of Global Small Molecule API Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Five Forces Analysis of Global Small Molecule API Market
Figure 11. Breakdown of Global Small Molecule API Market by Source, 2020-2027, % of Revenue
Figure 12. Contribution to Global 2021-2027 Cumulative Revenue by Source, Value ($ mn) and Share (%)
Figure 13. Global Small Molecule API Market: Synthetic API, 2017-2027, $ mn
Figure 14. Global Small Molecule API Market: Branded Synthetic API, 2017-2027, $ mn
Figure 15. Global Small Molecule API Market: Generic Synthetic API, 2017-2027, $ mn
Figure 16. Global Small Molecule API Market: Semi-synthetic API, 2017-2027, $ mn
Figure 17. Global Small Molecule API Market: Natural Origin, 2017-2027, $ mn
Figure 18. Breakdown of Global Small Molecule API Market by Type, 2020-2027, % of Revenue
Figure 19. Contribution to Global 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%)
Figure 20. Global Small Molecule API Market: Standard API, 2017-2027, $ mn
Figure 21. Global Small Molecule API Market: High Potency API (HPAPI), 2017-2027, $ mn
Figure 22. Global Small Molecule API Market: Branded HPAPI, 2017-2027, $ mn
Figure 23. Global Small Molecule API Market: Generic HPAPI, 2017-2027, $ mn
Figure 24. Breakdown of Global Small Molecule API Market by Therapeutic Area, 2020-2027, % of Revenue
Figure 25. Contribution to Global 2021-2027 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%)
Figure 26. Global Small Molecule API Market: Infectious Diseases, 2017-2027, $ mn
Figure 27. Global Small Molecule API Market: Oncology, 2017-2027, $ mn
Figure 28. Global Small Molecule API Market: Ophthalmology , 2017-2027, $ mn
Figure 29. Global Small Molecule API Market: Cardiovascular Disorders, 2017-2027, $ mn
Figure 30. Global Small Molecule API Market: Central Nervous System, 2017-2027, $ mn
Figure 31. Global Small Molecule API Market: Respiratory Disorders, 2017-2027, $ mn
Figure 32. Global Small Molecule API Market: Metabolic Diseases, 2017-2027, $ mn
Figure 33. Global Small Molecule API Market: Other Applications, 2017-2027, $ mn
Figure 34. Breakdown of Global Small Molecule API Market by Application, 2020-2027, % of Revenue
Figure 35. Contribution to Global 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 36. Global Small Molecule API Market: Clinical Use, 2017-2027, $ mn
Figure 37. Global Small Molecule API Market: Commercial Use, 2017-2027, $ mn
Figure 38. Breakdown of Global Small Molecule API Market by Manufacturer Type, 2020-2027, % of Revenue
Figure 39. Contribution to Global 2021-2027 Cumulative Revenue by Manufacturer Type, Value ($ mn) and Share (%)
Figure 40. Global Small Molecule API Market: Pharmaceutical Companies, 2017-2027, $ mn
Figure 41. Breakdown of Global Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue
Figure 42. Global Small Molecule API Market: CMOs, 2017-2027, $ mn
Figure 43. Breakdown of Global Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue
Figure 44. Global Market Snapshot by Region
Figure 45. Geographic Spread of Worldwide Small Molecule API Market, 2020-2027, % of Revenue
Figure 46. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value ($ mn) and Share (%)
Figure 47. North American Small Molecule API Market, 2017-2027, $ mn
Figure 48. Breakdown of North America Small Molecule API Market by Country, 2020 and 2027, % of Revenue
Figure 49. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 50. U.S. Small Molecule API Market, 2017-2027, $ mn
Figure 51. Canada Small Molecule API Market, 2017-2027, $ mn
Figure 52. Small Molecule API Market in Mexico, 2017-2027, $ mn
Figure 53. European Small Molecule API Market, 2017-2027, $ mn
Figure 54. Breakdown of European Small Molecule API Market by Country, 2020 and 2027, % of Revenue
Figure 55. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 56. Small Molecule API Market in UK, 2017-2027, $ mn
Figure 57. Small Molecule API Market in France, 2017-2027, $ mn
Figure 58. Small Molecule API Market in Germany, 2017-2027, $ mn
Figure 59. Small Molecule API Market in Spain, 2017-2027, $ mn
Figure 60. Small Molecule API Market in Italy, 2017-2027, $ mn
Figure 61. Small Molecule API Market in Russia, 2017-2027, $ mn
Figure 62. Small Molecule API Market in Rest of Europe, 2017-2027, $ mn
Figure 63. Asia-Pacific Small Molecule API Market, 2017-2027, $ mn
Figure 64. Breakdown of APAC Small Molecule API Market by Country, 2020 and 2027, % of Revenue
Figure 65. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 66. Small Molecule API Market in China, 2017-2027, $ mn
Figure 67. Small Molecule API Market in Japan, 2017-2027, $ mn
Figure 68. Small Molecule API Market in India, 2017-2027, $ mn
Figure 69. Small Molecule API Market in Australia, 2017-2027, $ mn
Figure 70. Small Molecule API Market in South Korea, 2017-2027, $ mn
Figure 71. Small Molecule API Market in Rest of APAC, 2017-2027, $ mn
Figure 72. South America Small Molecule API Market, 2017-2027, $ mn
Figure 73. Breakdown of South America Small Molecule API Market by Country, 2020 and 2027, % of Revenue
Figure 74. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 75. Small Molecule API Market in Argentina, 2017-2027, $ mn
Figure 76. Small Molecule API Market in Brazil, 2017-2027, $ mn
Figure 77. Small Molecule API Market in Chile, 2017-2027, $ mn
Figure 78. Small Molecule API Market in Rest of South America, 2017-2027, $ mn
Figure 79. Small Molecule API Market in Middle East and Africa (MEA), 2017-2027, $ mn
Figure 80. Breakdown of MEA Small Molecule API Market by Country, 2020 and 2027, % of Revenue
Figure 81. Contribution to MEA 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 82. Small Molecule API Market in UAE, 2017-2027, $ mn
Figure 83. Small Molecule API Market in Saudi Arabia, 2017-2027, $ mn
Figure 84. Small Molecule API Market in South Africa, 2017-2027, $ mn
Figure 85. Growth Stage of Global Small Molecule API Industry over the Forecast Period
Note: Product cover images may vary from those shown
  • Aurobindo Pharma Ltd.
  • Cambrex Corporation
  • Catalent, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Lonza Group
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wuxi AppTec Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll